What you need to know about the oncology deals landscape
Pharma investment in oncology is far and above all other therapeutic areas, with dealmaking and partnering a core strategy in that investment. In just the last 4 years, oncology deal values totaled a whopping $331 billion. From the top 20 pharma companies to small start-ups, oncology is pulling investment from across life sciences.
This webinar dives into pharma’s largest sector to examine: